Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Recurrent Intermediate/High Grade NHL and Mantle Cell Lymphoma
NCT00003039Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 1997
- Primary completion
- Apr 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in non-Hodgkin lymphoma (NHL), mantle cell lymphoma (MCL), sponsored by National Cancer Institute. Started Sep 1997; status: completed.
02
Drugs
alvocidib
03
Conditions
non-Hodgkin lymphoma (NHL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00003039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003039.